David Kirn

2019

In 2019, David Kirn earned a total compensation of $554.3K as Chief Executive Officer at 4D Molecular Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$111,800
Salary$430,000
Other$12,500
Total$554,300

Kirn received $430K in salary, accounting for 78% of the total pay in 2019.

Kirn also received $111.8K in non-equity incentive plan and $12.5K in other compensation.

Rankings

In 2019, David Kirn's compensation ranked 11,444th out of 13,971 executives tracked by ExecPay. In other words, Kirn earned more than 18.1% of executives.

ClassificationRankingPercentile
All
11,444
out of 13,971
18th
Division
Manufacturing
4,636
out of 5,701
19th
Major group
Chemicals And Allied Products
1,828
out of 2,200
17th
Industry group
Drugs
1,574
out of 1,886
17th
Industry
Biological Products, Except Diagnostic Substances
346
out of 389
11th
Source: SEC filing on April 6, 2021.

Kirn's colleagues

We found one more compensation record of an executive who worked with David Kirn at 4D Molecular Therapeutics in 2019.

2019

August Moretti

4D Molecular Therapeutics

Chief Financial Officer

News

You may also like